Elon Musk’s Million Minds to Mars Visionby Lilu Anderson 13.02.2024Elon Musk announces plan to send one million people to Mars, showcasing his commitment to space exploration. Challenges and ambitions ...
Hyderabad Angels Launches $13M Fund for Disruptive Startupsby Lilu Anderson 12.02.2024Hyderabad Angels Fund (HAF) unveils new venture capital fund of Rs 100 crore for nurturing disruptive startups focused on technology ...
Cooper Standard: Insider Promoted Amid CFO Shuffleby Terry Bingman 12.02.2024Cooper Standard promotes Alison Nudd to Vice President and Chief Accounting Officer, strengthening financial operations for future success.
Gilead’s $4.3B Bet on CymaBay’s Liver Drugby Mark Eisenberg 12.02.2024Gilead Sciences plans to acquire CymaBay Therapeutics for $4.3 billion, expanding their liver disease portfolio. The deal is expected to ...
Intuitive Machines: Stock Surge Ahead of Lunar Questby Lilu Anderson 12.02.2024Intuitive Machines' stock soars as it prepares for a historic moon mission. A successful landing would be a major achievement ...
InterDigital Names Ken Kaskoun CGO for Growthby Lilu Anderson 12.02.2024InterDigital appoints Ken Kaskoun as Chief Growth Officer to drive expansion in mobile and AI technology. The appointment strengthens InterDigital's ...
Anixa’s Ovarian Cancer Trial Progress: Promising Resultsby Terry Bingman 12.02.2024Anixa Biosciences advances Phase 1 clinical trial for ovarian cancer therapy, increasing dosage and showing promising results. Market responds positively ...
Gilead Acquires CymaBay: Liver Cure Leap?by Mark Eisenberg 12.02.2024Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Shopify Stock Surge: Truist Sets $90 Targetby Mark Eisenberg 12.02.2024Truist Securities raises price target for Shopify shares ahead of earnings report, predicting strong growth potential. Market sentiment is positive.
Novo Nordisk’s Sales Surge: Eyeing $7B Annual Investmentby Mark Eisenberg 12.02.2024Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...